Wang, Chun
Xu, Can-Xin
Alippe, Yael
Qu, Chao
Xiao, Jianqiu
Schipani, Ernestina
Civitelli, Roberto
Abu-Amer, Yousef
Mbalaviele, Gabriel
Article History
Received: 30 March 2017
Accepted: 23 May 2017
First Online: 7 July 2017
Competing Interests
: G.M. is co-founder of Confluence Life Sciences. R.C. receives research support from Pfizer, Inc. and Amgen, and holds stock of Amgen, Eli-Lilly and Merck & Co. They have no additional financial interests. All other authors declare no competing financial interests.